This research aims to aid in the discovery of developing a drug for treatment of NAFLD by obtaining a high-resolution structure of the 11 kDa G0S2 protein by NMR spectroscopy. This evidence concerns the gene G0S2 and metabolic dysfunction-associated steatotic liver disease.